CREATION.co

Our #IBD DOL Finder demo webinar hosted by Daniel Ghinn and Bernard G. is now available on demand. This comprehensive session provides in-depth insights into advanced strategies for identifying and engaging with online #HCPs in breast cancer. By registering, you’ll gain access to the full recording. Click here to register and watch now: https://lnkd.in/eFQ4NCFs

Don't know which healthcare professionals (HCPs) to invest in before, during and after #congress? Ahead of #SABCS24, Daniel Ghinn and Anni Neumann dive into the power of social media listening in our on-demand webinar, "Unlocking Hidden HCP Influence at congress." Discover how CREATION Pinpoint can help uncover the hidden impact of #HCPs at medical congresses. Gather more of these insights in our on-demand webinar. Register now to access the full webinar: https://lnkd.in/d2-qY-M4

In our Better Listening for Better Health podcast, CREATION.co CEO Daniel Ghinn speaks with Prof. Partha S Kar about how social media drives change in #diabetes care. Prof. Kar highlights how platforms like X, Facebook, and LinkedIn help him: 🔹 Share key information and science advancements 🔹 Connect with policymakers and patients 🔹 Foster authentic, impactful conversations His advice for HCPs? Start by observing both those you admire and those you don’t to gain a balanced perspective. Assess where you fit in, post respectfully to build your reputation, and once established, don’t shy away from sharing differing opinions authentically. Read the summary of the interview: https://lnkd.in/eM67r7WM #DigitalHealth #BetterListeningForBetterHealth

Here are this week’s key releases you need to know about: Interview with Professor Partha Kar: Katie Kennedy reviews a powerful podcast featuring Professor Partha S Kar, delving into how he’s using digital platforms to transform diabetes care and advocate for patient-centered healthcare. https://lnkd.in/eM67r7WM Press Release: X Marks the Spot—Healthcare Professionals Embrace X (Twitter): This release highlights how X (Twitter) has become a central hub for healthcare professionals, enabling advocacy, education, and meaningful pharma engagement. And we take a look at what’s happening with HCPs on other channels including Bluesky Social. https://lnkd.in/e22BDbm8 Follow CREATION.co for more helpful reads #Healthcare #LifeSciences #DigitalHealth #DOLInsights #Leadership #SocialMedia

Healthcare professionals (#HCPs) are taking to #social media platforms like X (formerly #Twitter) to spark change, educate, and connect – but they’re not stopping there. A study by CREATION.co reveals new insights into how HCPs are leveraging social media: Advocacy & campaigning: We found that HCPs on X amplify influential voices, blending medical expertise with political discourse. This intersection of #healthcare and politics has made X a hub for impactful policy change campaigns. Education: X leads in sharing academic insights, while platforms like #LinkedIn, #Instagram, and #TikTok add creative ways to reach peers and patients alike. Pharma engagement: Over 6,000 mentions of top #pharma companies like Pfizer and Moderna show how HCPs interact on breakthroughs, approvals, and innovations. The rise of #Bluesky: Could this emerging platform rival X for HCP engagement? Nearly 28% of leading HCP voices in type 2 diabetes discussions are already exploring Bluesky’s potential. As social media becomes a cornerstone for advocacy, education, and peer engagement, how will these trends shape the future of healthcare? Read more about this in our new press release.

Want to follow the hottest HCP social media trends? You could start here:

Daniel Ghinn and Bernard G. demonstrate valuable DOL impact insights using CREATION.co’s DOL finder focused on #breastcancer ahead of #SABCS next week. Explore how our DOL Finder demo helps you analyze HCP peer engagement and conversations across major congress meetings including #ASCO and #ESMO, while identifying key HCPs in oncology. Register now to access the full demo webinar on demand: https://lnkd.in/eQW53BD3 #DOLFinderDemo #OncologyLeadership #BreastCancerResearch

On September 27, the FDA approved Bristol Myers Squibb’s Cobenfy, a first-in-class treatment for schizophrenia in adults, reports Catherine Eckford in the European Pharmaceutical Review. “Today’s landmark approval of our first-in-class treatment for schizophrenia marks an important milestone for the community, where after more than 30 years, there is now an entirely new pharmacological approach for schizophrenia — one that has the potential to change the treatment paradigm,” said Chris Boerner, Board Chair and Chief Executive Officer at Bristol Myers Squibb. In our September Product Launch Tracker, we found that 68 HCPs posted about the approval of Cobenfy in 72 posts, including psychiatrist Prakash Masand, who described the approval as “exciting news for patients, caregivers, and clinicians”, and said that the treatment has a “a truly innovative mechanism of action”. Read more about what we heard in our Product Launch Tracker last month: https://lnkd.in/gGm6pzFN #cobenfy #schizophrenia #bristolmyerssquibb #WhatHCPsThink

Katie King, PhD says it's okay to dream big. In the latest episode of Better Listening for Better Health, Katie shares some encouraging words about her journey as a scientist with an ambitious vision to solve global health challenges—proving that the sky is not the limit. 🌌 Her research with BioOrbit into producing drugs in a microgravity environment could change the way we approach medicine on Earth. 💊 Tune in to discover more about her groundbreaking work and how space could be the future of cancer drug manufacturing. 🎧 Find the full episode on your favourite player: Space health will change how we treat #cancer: Katie King, PhD Youtube: https://lnkd.in/euQT4CcH Spotify: https://lnkd.in/e8N29CtS Apple: https://lnkd.in/e2iur3ZC Amazon: https://lnkd.in/eV52R2Kz #betterlisteningforbetterhealth #podcast #oncology #spacetech